Browsing by Subject "FDA adverse event reporting system"

Now showing items 1-2 of 2

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study

Rahman, Towsifur (Brac University, 2023-02)

Onychomycosis is a fungal infection in the nails. Oral antifungal therapies of onychomycosis; terbinafine, fluconazole, ravuconazole, otesaconazole may cause liver and acute kidney injury (AKI). This project aims to identify ...
A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death

Bakar, Osama Bin Abu (Brac University, 2023-02)

Alzheimer's Disease (AD) is a complex and common neurological disorder and dementia's leading cause. Memantine works to treat moderate to severe AD. This study focused on Food and Drug Administration Adverse Event Reporting ...